Cytotoxicity and gene expression changes induced by inorganic and organic trivalent arsenicals in human cells

Toxicology

Volumn 312, Issue 1, 2013, Pages 18-29

  Dodmane, Puttappa R ^a   Arnold, Lora L ^a   Kakiuchi Kiyota, Satoko ^b   Qiu, Fang ^c   Liu, Xiangde ^a   Rennard, Stephen I ^a   Cohen, Samuel M ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Bronchial; Cell proliferation; Cytotoxicity; Skin; Trivalent arsenicals; Urothelial

Indexed keywords

ARSENIC TRIOXIDE; DIMETHYLARSINOUS ACID; INTERFERON; MONOMETHYLARSONOUS ACID; ORGANOARSENIC DERIVATIVE; PROTEIN P53; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ARTICLE; BRONCHUS; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; LIPID PEROXIDATION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; STRESS; TARGET ORGAN;

BRONCHIAL; CELL PROLIFERATION; CYTOTOXICITY; SKIN; TRIVALENT ARSENICALS; UROTHELIAL;

ARSENIC POISONING; ARSENICALS; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HUMANS; SIGNAL TRANSDUCTION;

EID: 84882628707     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2013.07.008     Document Type: Article

References (58)

1. Adeyemi A., Garelick H., Priest N.D. A biokinetic model to describe the distribution and excretion of arsenic by man following acute and chronic intakes of arsenite/arsenate compounds by ingestion. Human Exp. Toxicol. 2010, 29:891-902.
2. Alam, M., Hazari, S.K.S., Alam, A.T., 2011. Prevalence of skin cancer in chronic arsenicosis in Chittagong Medical College Hospital. Journal of Chittagong Medical College Teachers' Association 21.
3. Arnold L.L., Nyska A., Eldan M., van Gemert M., Cohen S.M. Dimethylarsinic acid: results of chronic toxicity/carcinogenicity studies in F344 rats and B6C3F1 mice. Toxicology 2006, 223:82-100.
4. Arnold L.L., Suzuki S., Yokohira M., Kakiuchi-Kiyota S., Pennington K.L., Cohen S.M. Time course of urothelial changes in rats and mice orally administered arsenite. Toxicol. Pathol. 2013, 10.1177/0192623313489778.
5. Bailey K., Xia Y., Ward W.O., Knapp G., Mo J., Mumford J.L., Owen R.D., Thai S.-F. Global gene expression profiling of hyperkeratotic skin lesions from Inner Mongolians chronically exposed to arsenic. Toxicol. Pathol. 2009, 37:849-859.
6. Bailey K.A., Hester S.D., Knapp G.W., Owen R.D., Thai S.-F. Gene expression of normal human epidermal keratinocytes modulated by trivalent arsenicals. Mol. Carcinog. 2010, 49:981-998.
7. Chen C.-L., Hsu L.-I., Chiou H.-Y., Hsueh Y.-M., Chen S.-Y., Wu M.-M., Chen C.-J. Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan. JAMA 2004, 292:2984-2990.
8. Chen Y., Parvez F., Gamble M., Islam T., Ahmed A., Argos M., Graziano J.H., Ahsan H. Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol. Appl. Pharmacol. 2009, 239:184-192.
9. Chilakapati J., Wallace K., Ren H., Fricke M., Bailey K., Ward W., Creed J., Kitchin K. Genome-wide analysis of BEAS-2B cells exposed to trivalent arsenicals and dimethylthioarsinic acid. Toxicology 2010, 268:31-39.
10. Clewell H.J., Thomas R.S., Kenyon E.M., Hughes M.F., Adair B.M., Gentry P.R., Yager J.W. Concentration- and time-dependent genomic changes in the mouse urinary bladder following exposure to arsenate in drinking water for up to 12 weeks. Toxicol. Sci. 2011, 123:421-432.
11. Cohen S.M., Arnold L.L., Eldan M., Lewis A.S., Beck B.D. Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit. Rev. Toxicol. 2006, 36:99-133.
12. Cohen S.M., Arnold L.L., Uzvolgyi E., Cano M., St John M., Yamamoto S., Lu X., Le X.C. Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat. Chem. Res. Toxicol. 2002, 15:1150-1157.
13. Cohen S.M., Ohnishi T., Arnold L.L., Le X.C. Arsenic-induced bladder cancer in an animal model. Toxicol. Appl. Pharmacol. 2007, 222:258-263.
14. Da Rocha M.S., Dodmane P.R., Arnold L.L., Pennington K.L., Anwar M.M., Adams B.R., Taylor S.V., Wermes C., Adams T.B., Cohen S.M. Mode of action of pulegone on the urinary bladder of F344 rats. Toxicol. Sci. 2012, 128:1-8.
15. Dauphiné D.C., Ferreccio C., Guntur S., Yuan Y., Hammond S.K., Balmes J., Smith A.H., Steinmaus C. Lung function in adults following in utero and childhood exposure to arsenic in drinking water: preliminary findings. Int. Arch. Occup. Environ. Health 2011, 84:591-600.
16. De B.K., Majumdar D., Sen S., Guru S., Kundu S. Pulmonary involvement in chronic arsenic poisoning from drinking contaminated ground-water. J. Assoc. Physicians India 2004, 52:395-400.
17. Devesa V., Adair B.M., Liu J., Waalkes M.P., Diwan B.A., Styblo M., Thomas D.J. Arsenicals in maternal and fetal mouse tissues after gestational exposure to arsenite. Toxicology 2006, 224:147-155.
18. Dodmane P.R., Arnold L.L., Pennington K.L., Thomas D.J., Cohen S.M. Effect of dietary treatment with dimethylarsinous acid (DMA(III)) on the urinary bladder epithelium of arsenic (+3 oxidation state) methyltransferase (As3mt) knockout and C57BL/6 wild type female mice. Toxicology 2013, 305:130-135.
19. Drobna Z., Naranmandura H., Kubachka K.M., Edwards B.C., Herbin-Davis K., Styblo M., Le X.C., Creed J.T., Maeda N., Hughes M.F., Thomas D.J. Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate. Chem. Res. Toxicol. 2009, 22:1713-1720.
20. Flora S.J.S. Arsenic-induced oxidative stress and its reversibility. Free Radical Biol. Med. 2011, 51:257-281.
21. Gentry P.R., McDonald T.B., Sullivan D.E., Shipp A.M., Yager J.W., Clewell H.J. Analysis of genomic dose-response information on arsenic to inform key events in a mode of action for carcinogenicity. Environ. Mol. Mutagen. 2010, 51:1-14.
22. Hughes M.F., Beck B.D., Chen Y., Lewis A.S., Thomas D.J. Arsenic exposure and toxicology: a historical perspective. Toxicol. Sci. 2011, 123:305-332.
23. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Some Drinking-water Disinfectants and Contaminants, Including Arsenic 2004, IARC, International Agency for Research on Cancer, World Health Organization, France.
24. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., Speed T.P. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
25. Kenyon E.M., Hughes M.F., Adair B.M., Highfill J.H., Crecelius E.A., Clewell H.J., Yager J.W. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water. Toxicol. Appl. Pharmacol. 2008, 232:448-455.
26. Le X.C., Lu X., Ma M., Cullen W.R., Aposhian H.V., Zheng B. Speciation of key arsenic metabolic intermediates in human urine. Anal. Chem. 2000, 72:5172-5177.
27. Ling M.-P., Liao C.-M. Risk characterization and exposure assessment in arseniasis-endemic areas of Taiwan. Environ. Int. 2007, 33:98-107.
28. Lu M., Wang H., Li X.-F., Arnold L.L., Cohen S.M., Le X.C. Binding of dimethylarsinous acid to cys-13alpha of rat hemoglobin is responsible for the retention of arsenic in rat blood. Chem. Res. Toxicol. 2007, 20:27-37.
29. Lu T., Liu J., LeCluyse E.L., Zhou Y.S., Cheng M.L., Waalkes M.P. Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou China. Toxicol. Sci. 2001, 59:185-192.
30. Medeiros M., Zheng X., Novak P., Wnek S.M., Chyan V., Escudero-Lourdes C., Gandolfi A.J. Global gene expression changes in human urothelial cells exposed to low-level monomethylarsonous acid. Toxicology 2012, 291:102-112.
31. Menzel D.B., Rasmussen R.E., Lee E., Meacher D.M., Said B., Hamadeh H., Vargas M., Greene H., Roth R.N. Human lymphocyte heme oxygenase 1 as a response biomarker to inorganic arsenic. Biochem. Biophys. Res. Commun. 1998, 250:653-656.
32. Mo J., Xia Y., Wade T.J., DeMarini D.M., Davidson M., Mumford J. Altered gene expression by low-dose arsenic exposure in humans and cultured cardiomyocytes: assessment by real-time PCR arrays. Int. J. Environ. Res. Public Health 2011, 8:2090-2108.
33. National Research Council Arsenic in Drinking Water 1999, The National Academies Press, Washington, DC.
34. National Research Council Arsenic in Drinking Water: 2001 Update 2001, The National Academies Press, Washington, DC.
35. Pineda J., Herrera A., Antonio M.T. Comparison between hepatic and renal effects in rats treated with arsenic and/or antioxidants during gestation and lactation. J. Trace. Elem. Med. Biol. 2013, 10.1016/j.jtemb.2012.12.006.
36. R Development Core Team, 2004. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Vienna, Austria.
37. Ryker, S.K., 2001 Mapping arsenic in groundwater. 46, 34-36.
38. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3. Article3.
39. Storey J.D., Tibshirani R. Statistical significance for genomewide studies. PNAS 2003, 100:9440-9445.
40. Stueckle T.A., Lu Y., Davis M.E., Wang L., Jiang B.-H., Holaskova I., Schafer R., Barnett J.B., Rojanasakul Y. Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol. Appl. Pharmacol. 2012, 261:204-216.
41. Su P.-F., Hu Y.-J., Ho I.-C., Cheng Y.-M., Lee T.-C. Distinct gene expression profiles in immortalized human urothelial cells exposed to inorganic arsenite and its methylated trivalent metabolites. Environ. Health Perspect. 2006, 114:394-403.
42. Sugerman P.B., Bigby M. Preliminary functional analysis of human epidermal T cells. Arch. Dermatol. Res. 2000, 292:9-15.
43. Suzuki S., Arnold L.L., Ohnishi T., Cohen S.M. Effects of inorganic arsenic on the rat and mouse urinary bladder. Toxicol. Sci. 2008, 106:350-363.
44. Taketani S., Kohno H., Yoshinaga T., Tokunaga R. The human 32-kDa stress protein induced by exposure to arsenite and cadmium ions is heme oxygenase. FEBS Lett. 1989, 245:173-176.
45. 2-generating peroxisomal fatty acyl CoA oxidase. Int. J. Oncol. 1999, 15:743-749.
46. Thomas D.J. Molecular processes in cellular arsenic metabolism. Toxicol. Appl. Pharmacol. 2007, 222:365-373.
47. Tseng C.-H. Arsenic methylation, urinary arsenic metabolites and human diseases: current perspective. J. Environ. Sci. Health., Part C Environ. Carcinog. Ecotoxicol. Rev. 2007, 25:1-22.
48. Udensi U.K., Cohly H.H.P., Graham-Evans B.E., Ndebele K., Garcia-Reyero N., Nanduri B., Tchounwou P.B., Isokpehi R.D. Aberrantly expressed genes in HaCaT keratinocytes chronically exposed to arsenic trioxide. Biomark. Insights 2011, 6:7-16.
49. Vahter M. Mechanisms of arsenic biotransformation. Toxicology 2002, 181-182:211-217.
50. Valenzuela O.L., Germolec D.R., Borja-Aburto V.H., Contreras-Ruiz J., García-Vargas G.G., Del Razo L.M. Chronic arsenic exposure increases TGFalpha concentration in bladder urothelial cells of Mexican populations environmentally exposed to inorganic arsenic. Toxicol. Appl. Pharmacol. 2007, 222:264-270.
51. Wang H., Liu X., Umino T., Sköld C.M., Zhu Y., Kohyama T., Spurzem J.R., Romberger D.J., Rennard S.I. Cigarette smoke inhibits human bronchial epithelial cell repair processes. Am. J. Respir. Cell Mol. Biol. 2001, 25:772-779.
52. Wei M., Arnold L., Cano M., Cohen S.M. Effects of co-administration of antioxidants and arsenicals on the rat urinary bladder epithelium. Toxicol. Sci. 2005, 83:237-245.
53. Xie Y., Trouba K.J., Liu J., Waalkes M.P., Germolec D.R. Biokinetics and subchronic toxic effects of oral arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid in v-Ha-ras transgenic (Tg.AC) mice. Environ. Health Perspect. 2004, 112:1255-1263.
54. Xiong L., Wang Y. Quantitative proteomic analysis reveals the perturbation of multiple cellular pathways in HL-60 cells induced by arsenite treatment. J. Proteome Res. 2010, 9:1129-1137.
55. Xu Y., Wang Y., Zheng Q., Li B., Li X., Jin Y., Lv X., Qu G., Sun G. Clinical manifestations and arsenic methylation after a rare subacute arsenic poisoning accident. Toxicol. Sci. 2008, 103:278-284.
56. Yager J.W., Gentry P.R., Thomas R.S., Pluta L., Efremenko A., Black M., Arnold L.L., McKim J.M., Wilga P., Gill G., Choe K.-Y., Clewell H.J. Evaluation of gene expression changes in human primary uroepithelial cells following 24-hr exposures to inorganic arsenic and its methylated metabolites. Environ. Mol. Mutagen. 2013, 54:82-98.
57. Yan H., Wang N., Weinfeld M., Cullen W.R., Le X.C. Identification of arsenic-binding proteins in human cells by affinity chromatography and mass spectrometry. Anal. Chem. 2009, 81:4144-4152.
58. Yokohira M., Arnold L.L., Pennington K.L., Suzuki S., Kakiuchi-Kiyota S., Herbin-Davis K., Thomas D.J., Cohen S.M. Effect of sodium arsenite dose administered in the drinking water on the urinary bladder epithelium of female arsenic (+3 oxidation state) methyltransferase knockout mice. Toxicol. Sci. 2011, 121:257-266.